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Components of the complement system act directly on T cells to alter conventional and regulatory T cell sub-
sets. In this issue of Immunity, Kolev, Dimeloe, Le Friec et al. (2015) provide evidence of a mechanism by
which the complement stimulates sustained mTORC1 activation and regulates cellular metabolism.The complement (C’) cascade, along with
its regulatory proteins and receptors
for cleaved components, represents an
ancient metazoan mechanism for innate
host defense. In this setting, soluble pro-
teins in serum or interstitial fluids are
induced to execute sequential proteolytic
events after activation of the process
through one of three pattern-recognition
systems. Thus, classical, alternative, and
lectin (mannan-binding) mechanisms can
be stimulated through antibody-contain-
ing immune complexes and C1q, factor
B and properdin, or a mannan-binding
protein, respectively. Each of these path-
ways converges on a central gatekeeper,
the third complement component C3,
which is cleaved by a C3 convertase into
C3a and C3b fragments. C3b was long
known to exert two critical functions. In
one, C3b directs the next proteolytic
step, cleavage of C5 into a and b frag-
ments, leading ultimately to the formation
of a pore-forming membrane attack com-
plex. In the second, termed opsonization,
covalent C3b binding to circulating parti-
cles directs their engulfment by phago-
cytic cells. Both C3a and C5a bind to G
protein-coupled receptors (GPCRs), as
these complement fragments serve as
chemoattractants that can draw inflam-
matory cells to a site of heightened C’
activation. Within this picture, a fruit of
adaptive immunity (i.e., antigen-specific
Ab) functions together with an innate im-
mune mechanism through the classical
pathway.
Evolution—somewhat akin to parts of
Rome—often makes use of materials
already available as new layers of immu-
nity develop. C3d, a breakdown fragmentof C3b, binds to a receptor on B lympho-
cytes and thereby dramatically potenti-
ates their activation. Yet more recent
work provides fascinating further insights
into ways in which complement proteins
collaborate with or modulate adaptive im-
munity (Ricklin et al., 2010). In addition to
the long-known functions of C3 and C5
fragments, C3a and C5a act directly on
CD4+ T cells through their respective
GPCRs (Strainic et al., 2008) (Figure 1).
In a remarkable variation from the canon-
ical means of C3 cleavage and plasma-
lemmal receptor action, local generation
and autocrine function of C3a and C3b
(Strainic et al., 2008) were found to involve
intracellular C3 pools processed by the
protease cathepsin L (summarized in an
earlier Preview, Lajoie and Wills-Karp,
2013). Moreover, C3b binding to CD46
(membrane cofactor protein, MCP)—an
accessory protein of the complement
pathway—elicits signaling through the
cytoplasmic domain of some CD46 iso-
forms in a portion of the C3-activated
response.
C3aR and C5aR, in a partially redun-
dant manner, each improved the sur-
vival and proliferation of CD4+ T cells.
In addition, ligand-receptor interaction
stimulated phosphorylation of the ca-
nonical hydrophobic motif of AKT,
‘‘AKT(S473)’’ (Strainic et al., 2008), for
which the mammalian Target of Rapamy-
cin (mTOR) complex 2 (mTORC2) is the
main kinase in T cells (Lee et al., 2010).
Although a chemical inhibitor of phospha-
tidylinositol 3-kinases (PI3K) blocked this
induced phosphorylation, the molecular
mechanisms for mTOR stimulation or S6
phosphorylation downstream from C3aImmunityor C5a have not been clear. In this issue
of Immunity, Kolev, Dimeloe, Le Friec
et al. (2015) present exciting newevidence
toward elucidating these issues.Usinghu-
man CD4+ T cells, their work shows that
initial T cell activation resulted in induction
of LAMTOR5, a key component of the
multi-protein complex vital for enhance-
ment of mTORC1 activity at the surface
of the lysosome, and that LAMTOR5 was
essential for a late-phase mTORC1 activ-
ity 36 hr after T cell receptor cross-linking
(Figure 1). In particular, sufficiency of
certain key amino acids enhances
mTORC1 activity through a ‘‘Ragulator’’
complex that includes the LAMTOR gene
products and holds mTORC1 in the prox-
imity of the Rheb GTPase and a complex
of Rag proteins at the lysosome. Kolev
et al. (2015) assemble a combination of
confocal microscopy, RNAi, and human
T cells—including those of several pa-
tients with mutated CD46—to make the
case that CD46 and its cytoplasmic
domain is crucial for the mobilization and
persistence of mTORC1 activity. One of
the less developed areas of analysis for
understanding lymphocyte function is
that of later stages—whether and when
specific signaling pathways need to
remain active, and how they do so. The
findings of Kolev et al. (2015) are an impor-
tant window on approaching answers to
these questions in the setting of human
T cells.
Previous work from the Kemper group
and others has highlighted that CD46 is
important for the cytokine production pro-
files and quantities in the days after initial
activation of humanCD4+ T cells (summa-
rized in an earlier Preview, Lajoie and42, June 16, 2015 ª2015 Elsevier Inc. 977
Figure 1. CD46 Stimulates Amino Acid and Hexose Uptake and LAMTOR5 Expression to
Potentiate mTORC1 Signaling and Regulate Cytokine Gene Expression
Previous work has uncovered roles for C3a and C5a binding to their receptors on T cells. In this issue,
Kolev et al. (2015) provide evidence for a function of the C3b-binding protein CD46 in enhancing and sus-
taining signaling to mTORC1 as part of mechanisms by which complement components can regulate the
functional characteristics of T cells. During the early times after T cell activation, mTOR pathways have
been activated at lower levels, which can enhance glucose uptake via increased surface expression of
the hexose transporter GLUT1. In addition, induction of the amino acid transporter LAT1 accelerates
leucine uptake, thereby stimulating a higher level of mTORC1 activation at the lysosomal surface.
CD46-dependent enhancement of the expression of LAMTOR5, a component of the Ragulator complex
that helps link the RAG GTPases to the lysosome and Rheb, further potentiates this mechanism for sus-
taining mTORC1 activity and interference with the amino acid uptake or LAMTOR impedes induction of
IFN-g and IL-10 production in these activated T cells.
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first the frequency of interferon-g
(IFN-g)-expressing cells with a commen-
surate increase in production of this cyto-
kine and then, evenmore prominently, the
activation of interleukin-10 (IL-10) and
granzyme B production by a substantial
portion of these originally Th1 cells. The
CD46-driven IL-10 production can lead
the population to serve a suppressive
function, for instance in the setting of
anti-mycobacterial T cell responses
(Truscott et al., 2010). In light of emerging
findings about cellular metabolism and
T cell differentiation or function, a second
notable avenue pursued in the work of
Kolev et al. is their determination that
CD46 functions to change nutrient uptake
by their primary human CD4 T cells. Thus,
the authors discovered CD46-dependent978 Immunity 42, June 16, 2015 ª2015 Elsevchanges in expression of a major hexose
transporter, GLUT1, and of LAT1, a direc-
tional transporter for large neutral amino
acids that links to the integrin-associated
CD98hc protein, along with evidence of
CD46 cross-linking (Figure 1). The induc-
tion of LAT1 allows for enhanced leucine
uptake, which could stimulate mTORC1
activity via the sensor complex at the
lysosomal surface. Moreover, global ana-
lyses of transcript levels in cells from a
donor with mutated CD46 to those of a
healthy donor control showed a striking
enrichment for gene products linked to
metabolism. In parallel with their finding
of mTORC1 relocalization toward lyso-
somes along with increases in both extra-
cellular acidification (roughly speaking,
net lactic acid secretion) and oxygen
consumption rate stimulated by CD46ier Inc.cross-linking, the data make a case for a
significant contribution of CD46 signaling
to metabolic regulation. Finally, Kolev
et al. notably contribute to the small but
growing body of ‘‘interventional’’ experi-
ments with data on LAMTOR5 RNAi and
use of an inhibitor of amino acid transport
to indicate that the changes in meta-
bolism influence the resulting CD4
T cell functions, i.e., IFN-g and IL-10
production.
Strong scientific work raises countless
questions. Kolev et al. provides new
insight into a nexus of C3b-stimulated
CD46, metabolic regulation, mTORC1,
and aspects of the cytokine phenotype
in the human CD4 T cell. The growing
opera on metabolic profiles make a case
that, even as most simply designated
T cell subsets (Th1, Th2, Th17, Treg, Tfh,
etc.), each of the subsets has different
wiring of their intermediary metabolism.
All together, though, it will be vital to
sort out the terms of a balancing act be-
tween promoting an inflammatory effector
phenotype (likely associated most with
the simple Th1, IFN-g without IL-10) pro-
file versus suppressive or regulatory influ-
ences. How the mechanisms reported in
Kolev et al. influence the balance of
FoxP3 or more full-fledged Treg cell char-
acteristics—both thymus-derived and
peripherally induced—versus comple-
ment-induced Treg and how these are
altered across diverse populations of
patients with altered CD46 will be impor-
tant, if challenging, to discern. In the
mouse system, the induction of FoxP3
and Treg cell characteristics were sup-
pressed by the stimulation of the AKT
limb of complement receptor signaling
so that T cells doubly deficient in C3aR
and C5aR facilitated mouse Treg cell gen-
eration and function (Kwan et al., 2013). In
line with this, it will be vital to keep in sight
compelling evidence that major aspects
of how metabolism and its regulators or
mediators (e.g., mTOR) impact T cell
identity and function appear to depend
heavily on both the severity of perturba-
tion and the nature of immune challenge.
For instance, mTORC1 may be crucial
for functional Treg cells, and its absence
led to decreased Th2, as well as Th1 cell
development (Zeng et al., 2013; Yang
et al., 2013). In this regard, analyses of
C3-deficient patients after immunization
are intriguing. Such individuals would
lack the capacity to provide CD46 with
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able to complement regulation of APCs
and B cells in addition to T cells. Notwith-
standing the systemic nature of their
defect, the observation of vaccine-spe-
cific antibody responses in which the
Th2 cell-dependent isotypes (human
immunoglobulin G4 [IgG4] and IgE) were
most diminished (Pekkarinen et al.,
2015) suggests that analyses of the func-
tional subsets of circulating Tfh or mem-
ory Tfh cells in people with mutated
CD46will be important. CD46 phenotypes
run the gamut from normal health in the
absence of CD46 expression to atypical
hemolytic uremic syndrome to some
patients with common variable immuno-
deficiency. Yet more broadly, then, un-
derstanding why the spectrum ofperturbations in adaptive immunity of
CD46-mutated people is so broad offers
the possibility of important insights into
the modifiers of phenotype in vivo and hu-
man susceptibility to disease.
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Expression of distinct homing receptors guides adaptive immune cells to antigen-rich tissue. In this
issue of Immunity, Komarowska et al. (2015) describe an autocrine loop that is initiated by cardiac-ex-
pressed hepatocyte growth factor to direct T cells into the heart during inflammation and cardiac trans-
plant rejection.T cells are the main determinants of
adaptive immunity. Their presence in
target tissue is regulated by the expres-
sion of distinct sets of adhesion and che-
mokine receptors and required to fulfill
their immunological function. Naive and
effector/memory T cells are distinguish-
able by their adhesion factor signatures:
naive T cells can home only to lymph no-
des (via CCR7, L-selectin, and the integ-
rin LFA-1), whereas antigen-experienced
T cells can travel to almost any tissue via
many chemokine receptors and adhe-
sion molecules (Ley, 2014; Mora and
von Andrian, 2006). In order to return to
the tissue where the antigen is present,
there must be tissue tropism to allow a
site-directed action of adaptive immu-
nity. This is best documented for homing
to the skin and the gastrointestinal tract.Migration of primed T effector/memory
cells to skin involves the chemokine
receptors CCR4, CCR10, and CCR8
(McCully et al., 2012). T cells activated
in the mesenteric lymph nodes display
higher expression of CCR9 and a4b7 in-
tegrin (Zabel et al., 1999), which allows
their subsequent homing to the gut.
Beyond these findings, it has been chal-
lenging to identify unique tissue-homing
signatures. For instance, T cell accumu-
lation in atherosclerosis has been pro-
posed to be dependent on a variety
of chemokines, including CCR5, CCR7,
CXCR3, and CXCL10 among others,
but observations mainly stem from global
knock-out mouse models. Because
these chemokine receptors are also ex-
pressed on other immune cells, such as
dendritic or myeloid cells, their specificrole in T cell homing remains unclear (Li
and Ley, 2015).
If adhesion and chemokine receptors
are indeed executing T cell homing,
then what are the mechanisms imprinting
T cells initially to recall the origin of the
antigen exposure? Do tissue-derived fac-
tors induce specific sets of adhesion fac-
tors on T cells? In this issue of Immunity,
Komarowska et al. (2015) set out to
address this experimentally, by investi-
gating the role of hepatocyte growth fac-
tor (HGF) in T cell homing to the heart.
Although it has been proposed previously
that the chemokine receptors CXCR3
(and its ligand CXCL10) as well as
CCR4 are contributing to T cell accumu-
lation during heart transplantation (Han-
cock et al., 2001; Hu¨ser et al., 2005), it
was unknown how the myocardium42, June 16, 2015 ª2015 Elsevier Inc. 979
